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OBJECTIVE — The purpose of this study was to investigate relationships between inﬂam-
matory markers and components of a metabolic syndrome cluster in adolescents.
RESEARCH DESIGN AND METHODS — This was a cross-sectional analysis of an
Australian childhood cohort (n  1,377) aged 14 years. Cluster analysis deﬁned a “high-risk”
group similar to adults with metabolic syndrome. Relevant measures were anthropometry,
fasting insulin, glucose, lipids, inﬂammatory markers, liver function, and blood pressure.
RESULTS — Ofthechildren,29%fellintoahigh-riskmetabolicclustergroupcomparedwith
2% by a pediatric metabolic syndrome deﬁnition. Relative to the “low-risk” cluster, they had
higher BMI (95% CI 19.5–19.8 vs. 24.5–25.4), waist circumference (centimeters) (95% CI
71.0–71.8 vs. 83.4–85.8), insulin (units per liter) (95% CI 1.7–1.8 vs. 3.5–3.9), homeostasis
modelassessment(95%CI1.7–1.8vs.3.5–3.9),systolicbloodpressure(millimetersofmercury)
(95% CI 110.8–112.1 vs. 116.7–118.9), and triglycerides (millimoles per liter) (95% CI 0.78–
0.80 vs. 1.25–1.35) and lower HDL cholesterol (millimoles per liter) (95% CI 1.44–1.48 vs.
1.20–1.26). Inﬂammatory and liver function markers were higher in the high-risk group: C-re-
active protein (CRP) (P  0.001), uric acid (P  0.001), alanine aminotransferase (ALT) (P 
0.001), and -glutamyl transferase (GGT) (P  0.001). The highest CRP, GGT, and ALT levels
were restricted to overweight children in the high-risk group.
CONCLUSIONS — Cluster analysis revealed a strikingly high proportion of 14 year olds at
risk of cardiovascular disease–related metabolic disorders. Adiposity and the metabolic syn-
drome cluster are synergistic in the pathogenesis of inﬂammation. Systemic and liver inﬂamma-
tioninthehigh-riskclusterislikelytopredictdiabetes,cardiovasculardisease,andnonalcoholic
fatty liver disease.
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M
etabolic abnormalities such as in-
sulin resistance have become more
prevalent with the childhood obe-
sityepidemic(1).Thesefeatures,referredto
as the metabolic syndrome, are also associ-
ated with inﬂammatory markers such as C-
reactive protein (CRP) in children (2) and
adults (3). Elevated CRP levels are associ-
ated with cardiovascular end points, partic-
ularly in high-risk populations such as
those with type 2 diabetes (4).
Elevated liver enzyme levels in adoles-
cents with metabolic syndrome track dur-
ing childhood and are associated with
worsening of the cardiovascular risk proﬁle
in young adults (5). Furthermore, -glu-
tamyltransferase(GGT),amarkerofoxida-
tive stress, is related to the risk of adult
cardiovascular disease (6), and both GGT
and alanine aminotransferase (ALT) levels
predict the risk of type 2 diabetes (7). Uric
acid,anothermarkerofinﬂammation,isin-
dependently associated with hypertension,
cardiovascular risk, and mortality (8).
The relationship between inﬂamma-
torymarkersandindividualcomponentsof
metabolic syndrome is unclear. Salient
questions are whether increased inﬂamma-
tion is a result of some or all of the compo-
nents associated with metabolic syndrome
or whether (and to what extent) inﬂamma-
tion contributes to or causes metabolic syn-
drome. For example, it has been suggested
that increased inﬂammatory cytokines de-
rived from adipocytes may be partly re-
sponsible for the insulin resistance seen in
obese patients (9).
We aimed, ﬁrst, to deﬁne the propor-
tion of adolescents with a high risk of car-
diovascular and metabolic disorders
usingclusteranalysisratherthanarbitrary
deﬁnitions of metabolic syndrome. Sec-
ond, we aimed to identify differences in
CRP, uric acid, ALT, and GGT between
the “high-risk” and “low-risk” groups.
Third,weaimedtodissectouttherelative
importance of metabolic syndrome com-
ponents for CRP, uric acid, ALT, and GGT.
We used data from a cohort studied at age
14, before onset of confounding behaviors
such as heavy drinking or smoking.
RESEARCH DESIGN AND
METHODS— The West Australian
Cohort (Raine) Study has been described
elsewhere (10). A total of 2,804 pregnant
women serially recruited from King Ed-
ward Memorial Hospital delivered 2,868
live births. Follow-up examinations of
their children at 1, 2, 3, 5, 8, 10, and 14
years included longitudinal sociodemo-
graphic and anthropometric parameters.
The age 14 follow-up involved 2,337 eli-
gible participants; 1,695 physical assess-
ments were conducted, including
anthropometry and resting blood pres-
sure, and 1,377 fasting blood samples
were obtained. Adolescents born preterm
(37weeks’gestation)orwithcongenital
deformities and multiple births were ex-
cluded,resultingin1,293physicalassess-
ments and 1,106 fasting blood samples.
Only children without missing data were
used in the clusters (n  1,094).
Fasting blood samples from children
were analyzed at Royal Perth Hospital for
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cholesterol, HDL and LDL cholesterol,
CRP, and uric acid. Glucose was measured
by an automated Technicon Axon analyzer
(Bayer Diagnostics, Sydney, Australia) us-
ing a hexokinase method. Insulin was mea-
sured by automated radioimmunoassay
(Tosoh, Tokyo, Japan). Total cholesterol
and triglycerides were determined enzy-
matically on the Cobas MIRA analyzer
(Roche Diagnostics) with reagents from
Trace Scientiﬁc (Melbourne, Australia).
HDL cholesterol was determined on a hep-
arin-manganese supernatant (11). HDL2
and HDL3 cholesterol were determined us-
ing single precipitation (12). LDL choles-
terol was calculated using the Friedewald
formula (13), valid for TG 3.5 mmol/l.
For CRP, a high-sensitivity monoclonal an-
tibody assay (Dade Behring Marburg, Mar-
burg,Germany)withinterassayprecisionof
2.1–2.6% for values 0.5–14 mg/l was used.
Uric acid was assayed on the Technicon
Axon analyser using Technicon reagents
and methods (Bayer Diagnostics).
Homeostasis model assessment
(HOMA) was calculated by fasting insulin
(microunitspermilliliter)fastingglucose
(millimoles per liter)]/22.5 (14).
Resting blood pressure readings were
takenusinganoscillometricsphygmoma-
nometer (DINAMAP vital signs monitor
8100, DINAMAP XL vital signs monitor,
or DINAMAP ProCare 100) after children
were seated. The monitor was set to auto-
matically record readings every 2 min.
The average of the second and third read-
ings was calculated.
Family income when children were
aged14years(deﬁnedbyannualearnings
in Australian dollars [A$]: A$0–30,000,
A$30,001–60,000, A$60,001–78,000,
or A$78,001) was obtained by ques-
tionnaire from the primary caregiver.
Highest maternal education was obtained
by questionnaire when children were
aged 8 years (incomplete secondary
schooling, completed secondary school-
ing, technical qualiﬁcation or diploma, or
tertiary education).
Exercise in adolescence was deter-
mined by questionnaire by the frequency
of exercise causing breathlessness or
sweating (monthly or less, weekly, 2–3
times weekly, 4–6 times weekly, or
daily). Kilocalories per day were based on
food frequency diaries.
Informed consent was obtained from
parents and adolescents. Institutional
ethics committees approved the study.
Statistical methods
Data were analyzed using SPSS (version
15.0; SPSS, Chicago, IL). Transformation
to natural logarithms was used for vari-
ables not normally distributed. For CRP
valuesbelowthelowestdetectablelevelof
the assay (0.16 mg/l), half of the detect-
able value (0.08 mg/l) was assigned. CRP,
which could not be transformed appro-
priately, was analyzed as a categorical
variable in tertiles and as a continuous
logarithmically transformed variable.
The use of two-step cluster analysis
avoided arbitrary deﬁnitions of metabolic
syndrome,particularlybecauseadultcut-
offs are not applicable to children. This
technique, best applied to data with nat-
ural groupings, classiﬁes data into sub-
sets, known as clusters. Metabolic
syndrome is seen with groupings of risk
factors within an individual; hence, this
technique is well suited for identiﬁcation
ofahigh-riskcluster.Withinasingleclus-
ter, the subjects are relatively homoge-
neous, sharing similar traits and being
dissimilar to subjects in other clusters.
Thetechniqueusesascalableclusteranal-
ysis algorithm (15) designed speciﬁcally
to handle large datasets. It preclusters
subjects into subclusters before further
groupingintothedesirednumberofclus-
ters using log-likelihood distance. The
cluster groups were formed separately by
sex using triglycerides, BMI, HOMA, and
systolic blood pressure (SBP). This tech-
nique was previously used on a subset of
children aged 8 years to deﬁne a distinct
high-risk group with features consistent
with metabolic syndrome (10).
The prevalence of the cluster groups
was compared with the prevalence of
metabolic syndrome deﬁned by the Na-
tional Cholesterol Education Program
adult deﬁnition (16) and two modiﬁed
pediatric deﬁnitions of metabolic syn-
drome (17), one from the International
Diabetes Federation consensus (18).
The two cluster groups were com-
pared using one-way ANOVA for cardio-
vascular risk factors including BMI, waist
circumference, fasting insulin, HOMA,
lipids, and SBP. The cluster groups were
compared using one-way ANOVA for
CRP, GGT, ALT, and uric acid.
Evaluation of effects on
inﬂammatory markers of individual
metabolic syndrome components
Linearregressionwasundertakenforpre-
diction of GGT, ALT, and uric acid, ad-
justing for age and sex. Stepwise
regression models were formed, using as
independent covariates BMI, waist cir-
cumference, triglycerides, HOMA, SBP,
andHDLcholesterol.Asecondmodelad-
justed for socioeconomic status, puberty,
kilocalories per day, and exercise. Ordi-
nalandlinearregressionusingcategorical
groupsofCRPtertilesandlogarithmically
transformed CRP as outcomes were per-
formed. Both regressions revealed similar
results. Only linear regression results are
presented.
Becausecomponentsofthemetabolic
cluster are strongly interrelated, we ex-
plored the relative importance of each
component on inﬂammatory markers by
dividingthedataatthemedianofindivid-
ual components of metabolic syndrome,
namely, into high and low BMI, waist cir-
cumference, insulin, HOMA, triglycer-
ides, HDL cholesterol, and SBP. In each
instance, four groups were formed by
combinations of high-risk or low-risk
cluster with high or low individual
components. CRP, GGT, ALT, and uric
acid were compared among the four
groups using one-way ANOVA. The
majority (90%) of the adolescents
were Caucasian.
RESULTS
Cluster analysis
Using cluster analysis, 29.1% fell into the
high-risk cluster using HOMA, SBP, trig-
lycerides, and BMI at age 14 years as clus-
ter components. The high- and low-risk
clusters were comparable in age. The
high-risk children had lower family in-
come and lower maternal education and
were more likely to be female. The high-
risk group had greater weight, height,
BMI,waistcircumference,armcircumfer-
ence, insulin, glucose, triglycerides, LDL
cholesterol,totalcholesterol,andSBPand
lower HDL cholesterol (Fig. 1). By using
an adult deﬁnition (National Cholesterol
Education Program) (16) and pediatric
adapted deﬁnitions from the Interna-
tional Diabetes Federation (18) and
Cook/Ford (17) to deﬁne metabolic syn-
drome, prevalence was 1.8, 1.8, and
2.2%, respectively, in this cohort. All
identiﬁed with the syndrome using any
arbitrary cutoffs fell into the high-risk
cluster.
Association of cluster group with
inﬂammatory markers: inﬂammatory
markers/liver function tests
The high-risk cluster had signiﬁcantly
higher CRP, ALT, GGT, and uric acid
both for boys and girls separately and
combined (all P  0.001) (Table 1).
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GGT, ALT, and uric acid
The independent predictors of these vari-
ables using stepwise linear regression
showed that for each marker a measure of
adiposity explained the largest amount of
variance (17–28%) and that further met-
abolic syndrome components were addi-
tional independent predictors. For CRP
and uric acid, HDL cholesterol was an in-
dependent predictor. For ALT and GGT,
HOMA was an independent predictor.
For UA, SBP was an independent pre-
dictor (Table 2).
Predictors of CRP
Importance of adiposity and cluster
membership for CRP levels. To test
whether inﬂammation is associated with
obesity without other features of the met-
abolic syndrome cluster, we grouped
high- and low-risk children further ac-
cording to the BMI median, resulting in
four groups, namely 1) low-risk cluster,
low BMI; 2) low-risk cluster, high BMI; 3)
high-risk cluster, low BMI; and 4) high-
riskcluster,highBMI.CRPwashighestin
those in both the high-risk cluster and
high BMI groups (group 4). The over-
weight group in the low-risk cluster had
an intermediate CRP, higher than that of
theirleanercounterpartsbutsubstantially
lower than that of their overweight high-
risk counterparts. The high-risk children
with high BMI, both boys and girls, had
the highest CRP.
Similarly, four groups were formed
by dividing the high- and low-risk clus-
ters according to the waist circumference
median. Those with a high waist circum-
ference in the high-risk cluster had the
highest CRP (Fig. 2).
Relative importance of other meta-
bolic syndrome components for CRP
levels. In contrast with BMI and waist
circumference, SBP, HOMA (Fig. 2),
triglycerides, and HDL cholesterol were
notassociatedwithCRPwithineitherof
the risk cluster groups.
Predictors OF ALT, GGT, and uric
acid: importance of adiposity and
cluster membership for
aminotransferases and uric acid
ALT,GGT,anduricacidlevelsinthefour
groups deﬁned by cluster membership
and BMI median are shown (Fig. 2).
Figure 1—The features of the cluster groups with respect to components of the metabolic syndrome showing the 99% CIs.
Huang and Associates
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niﬁcantly higher ALT, GGT, and uric acid
than children in the other three groups.
This ﬁnding was seen in both sexes.
CONCLUSIONS — In this 14-year-
old population, a strikingly high propor-
tion, 29%, fell into a high-risk group with
features of metabolic syndrome, i.e., higher
BMI, insulin resistance (HOMA), SBP, and
triglyceridesandlowerHDLcholesterollev-
els. The high-risk group also exhibited sub-
stantially higher levels of inﬂammatory
markers, which are independently associ-
ated with cardiovascular disease and diabe-
tes in adults. Importantly, only overweight
adolescents within the high-risk group had
raised inﬂammatory markers.
Cluster analysis (10) of the individual
metabolic syndrome components was used
toavoiddeﬁnitionsrelyingonarbitrarycut-
offs,previouslyshowntobeinconsistentfor
diagnosing metabolic syndrome in adoles-
cence (19). The prevalence of metabolic
syndrome by conventional cutoffs was low
inthispopulation(2%)comparedwiththat
in other adolescent Western cohorts, in-
cluding the National Health and Nutrition
Examination Survey, with prevalence rang-
ingfrom2to9%usingmultipledeﬁnitions.
Meanwhile, the cluster approach, with the
useofcontinuousvariables,revealedalmost
15timestheprevalence(29%)ofchildrenat
risk. Despite the far higher prevalence of
children identiﬁed at risk by cluster analy-
sis, the high- and low-risk groups appeared
to be distinct populations with wide sepa-
ration of 99% CI for each of the metabolic
syndrome components (Fig. 1). Therefore,
this approach is powerful for public health
research into cardiovascular risk in a popu-
lation, as it allows identiﬁcation of larger
numbers at risk.
High adiposity was the strongest in-
dependent predictor of the inﬂammatory
markers, accounting for 17–28% of the
varianceinCRP,uricacid,ALT,andGGT,
notdissimilartotheresultseenforCRPin
other adolescent studies (20). However,
an important point was disclosed by this
study. Adiposity was exclusively associ-
ated with the highest levels of inﬂamma-
torymarkerswhenitwaspartofthehigh-
risk cluster, i.e., children with increased
adiposity in isolation showed levels of
CRP similar to those in leaner children,
best illustrated by division of the clusters
according to binary groupings of their
components(Fig.2).Thisapproachhelps
dissect out highly collinear data.
The NHANES study, using an arbi-
trary metabolic syndrome deﬁnition,
Table1—Generalcharacteristicsofgirlsandboysinthe“Rainecohort”atage14yearsandcharacteristicsofthechildreninthehigh-riskand
low-risk clusters
Girls Boys P Low-risk cluster High-risk cluster P
n 629 664 783 311
General characteristics
Age (years) 13.8 (13.7–13.8) 13.8 (13.7–13.8) 0.922 13.8 (13.7–13.8) 13.8 (13.8–13.8) 0.106
Maternal education (3 df)* 0.011†
Income group (3 df)‡ 0.001†
Male/female ratio 1.16 0.87 0.014†
Pubertal stage (boys)§ 2.8 (2.7–2.8) 2.8 (2.7–2.9) 2.8 (2.7–3.0) NS
Pubertal stage (girls)§ 3.0 (3.0–3.1) 3.3 (3.2–3.4) 3.4 (3.3–3.5) 0.032
Exercise (proportion
exercising to out of
breath daily) (%) 71 6 0.001† 14 9 0.014†
Anthropometry
Weight (kg) 57.1 (56.1–58.1) 58.4 (57.3–59.4) 0.086 53.4 (52.9–54.0) 69.4 (67.8–70.9) 0.001
Height (m) 1.62 (1.62–1.63) 1.66 (1.66–1.67) 0.001 1.64 (1.64–1.64) 1.65 (1.64–1.66) 0.032
Waist circumference (cm)¶ 74.7 (73.9–75.6) 76.1 (75.2–77.0) 0.028 71.4 (71.0–71.8) 84.6 (83.4–85.8) 0.001
BMI (kg/cm
2)¶ 21.7 (21.4–22.0) 21.0 (20.7–21.3) 0.003 19.6 (19.5–19.8) 24.9 (24.5–25.4) 0.001
Arm circumference (cm) 25.3 (25.0–25.5) 25.3 (25.0–25.5) 0.921 24.1 (24.0–24.3) 28.2 (27.9–28.6) 0.001
Inﬂammatory markers/liver
function tests
CRP (mg/l)¶ 0.33 (0.29–0.37) 0.33 (0.29–0.36) 0.876 0.27 (0.25–0.29) 0.65 (0.57–0.73) 0.001
CRP (girls)¶ 0.27 (0.24–0.29) 0.58 (0.49–0.69) 0.001
CRP (boys)¶ 0.28 (0.25–0.31) 0.73 (0.60–0.88) 0.001
GGT (U/l)¶ 9.6 (9.3–9.8) 12.1 (11.8–12.4) 0.001 10.4 (10.2–10.6) 12.1 (11.7–12.6) 0.001
GGT (girls)¶ 9.2 (8.9–9.4) 10.6 (10.1–11.1) 0.001
GGT (boys)¶ 11.7 (11.4–12.0) 14.2 (13.5–14.9) 0.001
ALT (U/l)¶ 13.6 (13.2–14.0) 17.6 (17.0–18.1) 0.001 15.1 (14.8–15.5) 17.1 (16.4–17.7) 0.001
ALT (girls)¶ 0.001
ALT (boys)¶ 0.001
Uric acid (mmol/l) 0.27 (0.27–0.28) 0.32 (0.32–0.33) 0.001 0.29 (0.29–0.29) 0.32 (0.31–0.33) 0.001
Uric acid (girls) 0.26 (0.26–0.27) 0.29 (0.28–0.30) 0.001
Uric acid (boys) 0.32 (0.31–0.32) 0.35 (0.34–0.36) 0.001
Data are means (95% CI). *Deﬁned by education not higher than secondary schooling, completed secondary schooling, higher education including technical
qualiﬁcation or diploma, or tertiary education. †
2 testing. ‡Deﬁned by annual earnings in Australian dollars (A$) A$0–30,000, A$30,001–60,000, A$60,001–
78,000, and A$78,001. §Subset of adolescents correctly shown the Tanner staging pictures. Deﬁned by exercise to an out-of-breath state once a month or less,
once a week, 2–3 times per week, 4–6 times a week, or every day. ¶Around geometric mean. df, degrees of freedom.
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abolic syndrome was associated with
higher CRP than being overweight with-
out the syndrome (21). However, in con-
trast with our ﬁndings, NHANES showed
that CRP was high in the few individuals
with normal weight who had the
syndrome. Our approach with cluster
analysis probably yielded different sub-
populations. In the present study, the use
of cluster analysis rather than the restric-
tive deﬁnitions of metabolic syndrome
usedelsewheretoassessassociationswith
inﬂammatorymarkersenabledustoiden-
tify a broader section of the adolescent
population at risk of cardiovascular and
metabolic disease.
Increased levels of GGT, CRP, and
uric acid in the high-risk cluster in our
study are also notable; each has been
shown to be a strong predictor of adult
cardiovascular disease (3,6,8), indepen-
dent of the individual components of the
metabolic cluster.
The association between aminotrans-
ferases and the metabolic cluster is con-
sistent with persistent elevation of ALT
and GGT in those with elevated cardio-
vascular risk in the Bogalusa study (5).
Because GGT predicts both type 2 diabe-
tes (7) and cardiovascular mortality in
adults(6),thisassociationfurtherempha-
sizes the heightened potential for prema-
ture ill health for the 14 year olds in the
metabolic cluster.
There were noteworthy differences be-
tweenthemarkersweinvestigatedandtheir
relationship to metabolic syndrome com-
ponents. Speciﬁcally, 1) HDL cholesterol
wasrelatedtoCRPanduricacid,2)SBPwas
related to uric acid, and 3) HOMA was re-
latedtotheaminotransferases.Theseresults
suggest that each inﬂammatory marker
evolves via different pathways.
Aminotransferases were predicted by
HOMA levels in our study. Therefore,
liver inﬂammation is associated with adi-
posity and insulin resistance in adoles-
cents, as in adults with nonalcoholic fatty
liver disease (NAFLD) (22). This ﬁnding
implies that a large proportion of 14 year
olds (29% in the high-risk cluster) are at
risk of developing NAFLD and its se-
quelae,bearinginmindthattheincidence
of NAFLD will increase as the current
overweight youth reach adulthood.
Uric acid is associated with the preva-
lence of the metabolic syndrome (8). How-
ever, our results indicate that uric acid has
different associations with other inﬂamma-
tory markers. Uric acid was independently
associated with SBP and HDL cholesterol.
The relation between uric acid and blood
pressure is consistent with that in studies
showing elevated uric acid with hyperten-
sioninadults,inyouth(23),andinwomen
with preeclampsia, for which hypertension
isahallmark.Incontrast,anassociationbe-
tween uric acid and HDL cholesterol, inde-
pendent of adiposity, has not previously
been reported in youth, although it was
hinted at by the independent association
between uric acid and the triglyceride–to–
HDL cholesterol ratio in 352 middle-aged
men (24). In our study, not only did HDL
cholesterolindependentlypredicturicacid,
but also the highest levels of uric acid oc-
curred in the high-risk cluster with low
HDL cholesterol (data not shown). The ex-
planationforthisassociationisunclear,but,
if causal, it may be related to the anti-
inﬂammatory effects of HDL cholesterol
(25).
Cautionisneededinpostulatingcausa-
tion from a cross-sectional study. It is pos-
sible that in using stepwise regression for
identifying predictors of the markers, the
variables selected may be surrogates, ap-
pearing in the model when measured with
less error or in place of unmeasured vari-
ables. However, lack of adult confounders
in our young population may be advanta-
geousinclarifyingcausalpathways.Webe-
lieve that the metabolic cluster in our
adolescents signals disease processes early
in evolution before other downstream ef-
fects. Discrepancies between adolescent
and adult studies may relate to secondary
effects of advanced vascular disease and
pathological changes concomitant with ag-
ingorcomplicatingeffectsoflifestylefactors
suchassmoking.Ourstudyhelpsinunder-
standingthecriticalearlystepsinthepatho-
genesis of inﬂammation and the metabolic
syndrome. The biomarkers studied are on
pathwaysofinﬂammation,alongwithcyto-
kines such as interleukin-6 and tumor ne-
crosis factor-, previously shown to be
closely related to adiposity. Longitudinal
data will be available for a high proportion
of adolescents with future follow-ups and
willbeofconsiderableinterestinunraveling
the evolution of cardiovascular risk during
the transition to adulthood.
Table 2—Linear regression models for deﬁning independent predictors of CRP, GGT, ALT,
and uric acid
Outcome Variables* Adjusted r
2†  coefﬁcient SEM P
ln(CRP) ln(BMI) 0.25 2.17 0.37 0.001
ln(waist) 0.25 1.64 0.49 0.001
HDL cholesterol 0.26 	0.29 0.098 0.003
ln(GGT) ln(BMI) 0.22 0.40 0.05 0.001
ln(TG) 0.24 0.09 0.021 0.001
ln(HOMA) 0.24 0.04 0.016 0.008
ln(ALT) ln(waist) 0.16 0.47 0.081 0.001
ln(HOMA) 0.17 0.05 0.018 0.006
SBP 0.17 0.00 0.001 0.04
Uric acid ln(waist) 0.28 0.08 0.026 0.004
SBP 0.30 0.00 0 0.001
HDL cholesterol 0.31 	0.02 0.005 0.001
ln(BMI) 0.31 0.05 0.019 0.005
Variables‡
CRP tertile ln(BMI) 0.26 2.34 0.51 0.001
HDL cholesterol 0.27 	0.48 0.14 0.001
ln(waist) 0.27 1.91 0.68 0.005
ln(TG) 0.28 	0.23 0.11 0.033
ln(GGT) ln(BMI) 0.21 0.39 0.06 0.001
ln(TG) 0.23 0.09 0.03 0.001
ln(HOMA) 0.23 0.05 0.02 0.030
ln(ALT) ln(waist) 0.18 0.62 0.09 0.001
SBP 0.18 0.00 0.001 0.042
Uric acid ln(BMI) 0.28 0.07 0.02 0.008
SBP 0.29 0.00 0.0002 0.001
HDL cholesterol 0.30 	0.02 0.006 0.003
ln(waist) 0.31 0.07 0.03 0.037
*Adjustedforageandsex.†Forprogressivestepwisemodels.‡Adjustedforage,sex,maternaleducationand
family income, puberty, and exercise (kilocalories/day). TG, triglycerides.
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DIABETES CARE, VOLUME 32, NUMBER 4, APRIL 2009 699Figure 2—A: CRP in relation to cluster membership and median splitting of BMI, waist circumference, SBP, and HOMA. **P  0.001 compared
with the reference group (low-risk cluster and low BMI). ##P  0.001 for difference between the two groups indicated. 1, below the median level
of a particular component of the metabolic syndrome (BMI, waist circumference, SBP, or HOMA); p, above the median level of a particular
component of the metabolic syndrome (BMI, waist circumference, SBP, and HOMA). B: GGT, ALT, and uric acid in relation to cluster membership
and median splitting of BMI. **P  0.001 compared with the reference group (low-risk cluster and low BMI). ##P  0.001 for difference between
the two groups indicated. 1, below the median of BMI; p, above the median of BMI.
Inﬂammation and metabolic cluster in adolescents
700 DIABETES CARE, VOLUME 32, NUMBER 4, APRIL 2009In summary, cluster analysis demon-
strates that approximately 30% of 14-year-
old predominantly Caucasian Australian
children exhibit early features of the meta-
bolic syndrome accompanied by a range of
inﬂammatory markers. In addition to em-
phasizingthemagnitudeoftheproblemina
proximate adolescent population, the ﬁnd-
ings extend current understanding in sev-
eralways.Theresultssuggestthatadiposity
in isolation is insufﬁcient to cause inﬂam-
mation but requires the synergistic effect of
other features of the metabolic syndrome
cluster, particularly insulin resistance and
dyslipidemia. Furthermore, different asso-
ciations of metabolic syndrome compo-
nents with inﬂammatory markers suggest
thatthemetabolicsyndromeislikelytobea
heterogeneous condition produced via dif-
ferentpathways,withimplicationsforadult
pathological conditions such as diabetes,
NAFLD, and hypertension. We previously
reported the effect of perinatal factors and
earlyweightgainoncardiovascularriskin8
year olds from this cohort (10). The results
from these 14 year-olds highlight the need
for effective childhood intervention to pre-
vent obesity, diabetes, adult cardiovascular
disease, and NAFLD.
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